Belluscura, a medical device company based in the United Kingdom, is dedicated to improving the health of Chronic Obstructive Pulmonary Disease (COPD) patients through the development of oxygen enrichment technology. COPD is a serious condition affecting millions of people, and Belluscura aims to create more favorable economic outcomes for patients, providers, and insurance companies. With COPD ranking as the third leading cause of death in the United States, Belluscura's mission is more important than ever.
Belluscura PLC's ticker is BELL
The company's shares trade on the LSE stock exchange
They are based in London, England
There are 1-10 employees working at Belluscura PLC
It is https://www.belluscura.com/
Belluscura PLC is in the Healthcare sector